Semaglutide entering a blood vessel causes rapid absorption into systemic circulation within minutes, potentially triggering sudden nausea, dizziness, rapid heartbeat, or sweating
Always discuss supplement additions with your provider, as timing relative to semaglutide administration matters
#AcuteDecompensation #ACLF #Inflammation #LiverDisease #GENFIT #G1090N *G1090N is an investigational drug candidate.* European Foundation for the Study of Chronic Liver Failure (EF CLIF), European Liver Patients' Association - ELPA Global Liver Institute American Liver Foundation To view or add a comment, sign in Following recent Phase 1 data that provided a solid foundation for advancing G1090N into Phase 2 proof-of-concept studies across the ACLF continuum, explore our latest scientific poster presented at AASLD 2025 to learn more about its active metabolite and earlier body of evidence
Take a fluttering heartbeat, for example
Symptoms can include seizures, agitation, anxiety, increased heart rate and blood pressure, insomnia, nausea and vomiting, and paranoia
BBB imaging clinically is still limited to contrast-enhanced or nuclear medicine techniques, making it only accessible to centers where contrast agents/tracers can be readily accessed
.webp)
